Nanbiosis among the European Research Infrastructures working for COVID-19 Pandemics

In response to the COVID-19 pandemic, several research infrastructures (RIs) NANBIOSIS among them, have set up specific services, such as rapid or fast track access, to allow researchers to obtain results as soon as possible.

The Association of European-Level Research Infrastructures Facilities (ERF-AISBL), collects the relevant information about the initiatives on a dedicated website.

NANBIOSIS provides rapid access for COVID-19 research. The ICTS offers preclinical stages services of biomedical product development, specifically, synthesis and preparation of biomolecules like antibodies, peptides, recombinant proteins, oligonucleotides for diagnostic therapeutic and prophylactic purposes.